{"id":"W2978430228","doi":"10.1016/s2213-8587(19)30264-5","title":"Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement","year":2019,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal; Western University","funders":"Janssen Pharmaceuticals; Silence Therapeutics; Akebia Therapeutics; Eli Lilly and Company; Lundbeckfonden; Novartis; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Novo Nordisk; Daiichi-Sankyo; Medicines Company; Ionis Pharmaceuticals; Institut de Cardiologie de Montréal; AstraZeneca; REGENXBIO; Regeneron Pharmaceuticals; Amgen; Boehringer Ingelheim; Unilever; European Commission; Meso Scale Diagnostics; European Atherosclerosis Society; Sanofi; MedImmune; HLS Therapeutics; GlaxoSmithKline; Merck; Pfizer","keywords":"Medicine; Task force; Intensive care medicine; Family medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001094416,0.0007454351,0.003566736,0.0001294663,0.0001901841,0.00005923085,0.0008874668,0.0001767166,0.0001512993],"category_scores_gemma":[0.00006271594,0.0005037569,0.001112219,0.0004684649,0.00009541398,0.00002109407,0.000923146,0.0007978243,0.00234987],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003956149,"about_ca_system_score_gemma":0.0001583714,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001143142,"about_ca_topic_score_gemma":0.00001441238,"domain_scores_codex":[0.9945269,0.0008167743,0.000895708,0.001104666,0.0005130679,0.00214286],"domain_scores_gemma":[0.9962524,0.000231012,0.0003186981,0.002765495,0.0001037934,0.0003285665],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004634291,0.00005884326,0.0001254688,0.01019195,0.004067133,0.00004774966,0.0003485345,0.000007688916,0.00007189013,0.0002528311,0.03066379,0.9541178],"study_design_scores_gemma":[0.001316955,0.0003010279,0.000862503,0.00453434,0.003438893,0.000008831562,0.00008330772,0.000002668312,0.00002461083,0.0000332155,0.9888954,0.0004982446],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.006390234,0.9796365,0.0001200635,0.00184169,0.0009495853,0.005957597,0.0007548551,0.0002612839,0.00408812],"genre_scores_gemma":[0.0008445404,0.9821216,0.002465937,0.009403866,0.002429629,0.0005700789,0.0005125931,0.0002463171,0.001405448],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9582316,"threshold_uncertainty_score":0.9997414,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06134634696561439,"score_gpt":0.3150195122342768,"score_spread":0.2536731652686623,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}